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Cancer metastasis linked to macrophage size, shape,
and metabolism
Peter J. Murray
Using macrophage morphology in human colorectal cancer liver metastasis, Donadon et al. in this issue of JEM (https://doi.
org/10.1084/jem.20191847) provide a window into lipid metabolism and foamy macrophages, which accrue in numerous
pathological states and here are shown to have clinical application.
Large, lipid-laden “foamy” macrophages are
frequently observed in cancer, atherosclero-
sis, and infectious diseases such as tubercu-
losis (TB; Molgora et al., 2020; Neyrolles,
2014; Remmerie and Scott, 2018). While po-
tentially linked to increased phagocytosis, for
example of lipids and cholesterol in athero-
sclerosis, the formation and function of
foamy macrophages remain a mystery.
Through an unbiased assessment of mac-
rophage morphology in human colorectal
cancer (CRC) liver metastasis, Donadon
et al. (2020) provide an unexpected win-
dow into understanding macrophage lipid
metabolism, concurrent with a new and
simple way of stratifying metastasis risk for
CRC patients. Donadon et al. (2020) found a
striking correlation between the presence
of L-TAMs (large tumor-associated macro-
phages) in CRC metastasis and poor out-
comes; the difference compared with the
numbers of S-TAMs (small TAMs) in the
same anatomical confine was sufficiently
significant so that it could be readily re-
duced to a simplified and automated pa-
thology screening tool.
Metastatic seeding of the liver from colon
carcinomas is an important driver of morbid-
ity and mortality from colon cancer. Within
the liver, metastatic lesions are readily dis-
tinguished from the normal liver architecture
and are infiltrated with macrophages within
the tumor bed and at the invasive margins
(Oliveira et al., 2019). Donadon et al. (2020)
stained CRC liver sections for CD68 or CD163
(commonly used markers for macrophages,
especially in tissues). As they note, an initiat-
ing idea for the study was to try to distinguish
different macrophage activation states in and
around the tumor. However, CD68 or CD163
stained two types of macrophages they named
S-TAM and L-TAM that were readily distin-
guished by size differential, allowing quanti-
fication by morphometric methods (see
figure). (In this regard, the regular histological
structure of the normal liver is an advantage
to spot both metastatic margins and macro-
phages.) Based on their corresponding RNA
sequencing and single-cell RNA sequencing
data, we can safely assume that L-TAMs are a
type of Kupffer cell (KC), or locally activated
KC. L-TAMs express CD5L,MARCO, and VCAM,
components of a hallmark gene expression
profile of KCs observed in other granular
studies of the human liver (MacParland et al.,
2018; Ramachandran et al., 2019). L-TAMs
were enriched with many mRNAs associated
with lipid metabolism, consistent with their
foamy appearance. By contrast, S-TAMs have a
distinct mRNA profile characterized by in-
flammatory gene expression. Perhaps S-TAMs
derive from the blood monocyte pool and lo-
cally differentiate under the influence of the
inflammatory tumor environment. However,
at this point, the exact relationships between
the different macrophages in the liver bearing
metastatic lesions can only be inferred by cor-
relation of gene expression to known patterns.
Donadon et al. (2020) then analyzed the
association between L-TAMs and S-TAMs
at the peritumor regions of 101 CRC pa-
tients and their clinical outcomes. First, they
found that neither macrophage density nor
expression of CD163 had any clear link to
key clinical parameters and outcomes; this
is somewhat surprising, as macrophage
number is often correlated with poor out-
comes in cancer (Cassetta and Pollard,
2018), which may be indicative of the liver
microenvironment in CRC. Second, using
morphometric techniques, they found a re-
markable relationship between L-TAMs and
survival after hepatectomy: the disease-free
survival of patients with a high L-TAM
area was 0.2% compared with patients
with higher S-TAMs of 27.8%. From these
findings, a clear clinical implication is that
macrophage morphology can stratify CRC
patients, which could be facilitated by the
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simplicity of the approach: simple histopa-
thology and unbiased morphometric scor-
ing could speed patient analysis. Although
Donadon et al. (2020) used a relatively
limited sample number, their results are so
clear-cut that expanding to a larger and
blinded test group should be an imperative.
However, the key scientific question that
emerged concerns the underlying reasons
for the association between L-TAMs and
cancer. Why are lipid-laden macrophages
linked to cancer progression? Clearly, much
new biology needs to be learned about the
specific macrophage activation and meta-
bolic states in specific tissue environs in
and around cancer.
What about the biology of the foamy
macrophages and their relationship to dis-
ease? As noted above, lipid-laden macro-
phages are frequently observed in different
pathological states. In TB, they correlate with
caseating necrosis and may be a “safe harbor”
for bacterial growth because they could sup-
ply a reservoir of triglycerides for bacterial
growth (Neyrolles, 2014). However, the fact
that foamy macrophages are common to di-
verse pathologies argues that they arise be-
cause of specific metabolic adaptations. There
are two obvious pathways that could influ-
ence the formation of foamy macrophages.
First, they could arise as a consequence of a
relative increase in phagocytic activity. It is
easy to imagine that considerable cell death
and debris accrue in TB and inside the ne-
crotic regions of solid tumors or in athero-
sclerotic lesions. The continual consumption
of cell material would certainly require ways
of breaking down biological polymers, mac-
romolecules, and of course lipids from
membranes. A second non–mutually exclu-
sive possibility concerns the bioenergetic re-
quirements of macrophages under hypoxia. In
hypoxia, oxygen is obviously limited, and,
therefore, electron disposal along the electron
transport chain (ETC) of mitochondria is also
limited. Similarly, activated microbial and
interferon-activated murine macrophages
generate free radicals such as nitric oxide
(NO) that poisons components of the ETC
such as aconitase, disabling mitochondrial
function (Everts et al., 2012; Palmieri et al.,
2020). (Human macrophages do not make
NO at anywhere close to the amount of mu-
rine macrophages, but still generate free rad-
icals; thus, the same principle may apply.)
Under inflammation, hypoxia, or both, gly-
colysis will be the main way of generating
energy. The “glycolytic switch” to Warburg-
type metabolism occurs during M1-biased
macrophage activation and is associated
with increased triglyceride synthesis, which
is essential for full inflammatory function
(Castoldi et al., 2020). These correlations form
a greater puzzle about foamy macrophages.
However, since lipid-laden macrophages are
common to so many disease states involving
hypoxia (e.g., TB granulomas, the relative hy-
poxia of the liver, especially in cancer), one
plausible pathway to account for foamy mac-
rophage formation is that hypoxia or disabled
mitochondria force the cell to dispose of
electrons from other catabolic pathways
through the biosynthesis of lipids, which are
then stored until they can be metabolized by
oxidation through a functioning ETC.
From studying CRC metastasis pathology,
Donadon et al. (2020) therefore provided two
new insights. The first is practical: can liver
histology with automated image analysis and
one stain be used to stratify risk in CRC? Sec-
ond, if foamy macrophages (in this case,
L-TAMs) accumulate and contribute to pathol-
ogy, a clear implication from their negative
correlation with disease-free survival, does the
metabolic adaptation of macrophages to the
foamy phenotype give us clues about weak
points in which they could be eliminated in
disease? For example, should lipid droplet for-
mation be an obligate requirement for survival
under hypoxia, a drug that disrupted lipid bio-
synthesis or storage may force the death of
these specific macrophages. Given the tremen-
dous research activity on the field of immune
cell metabolism, lipid homeostasis is likely to
come to the forefront given its clear link to di-
verse diseases.
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S-TAMs and L-TAMs populate metastatic CRC in the liver. The quantity of L-TAMs in and around the in-
vading tumor dictate, in part, survival outcomes frommetastatic disease in the liver. The origins of the S- and
L-TAMs can only be inferred from correlation to gene expression patterns. Depicted is a hypothetical or-
ganization where blood monocytes seed the S-TAM pool and L-TAMs arise from local KCs. However, further
experiments are necessary to establish the precise ontogeny of the different macrophages.
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